Mullin departs Medium’s OneZero

Emily Mullin, who had been reporting on biotech for Medium’s OneZero publication, is among those who have taken its buyout offer.

“I’m grateful to have had the opportunity to pursue meaningful stories about biotechnology and society over the past two years,” she wrote on Twitter.

Emily Mullin

Mullen was previously a freelance writer who has had bylines in The Washington Post, The Wall Street Journal, Scientific American, National Geographic, The Atlantic, Science, Quartz, Pacific Standard, and The Baltimore Sun, among others.

Her areas of interest include gene therapy, CRISPR, consumer genetics, reproductive technology, brain implants, regenerative medicine, biohacking, and AI in medicine.

She has also worked as associate editor for biomedicine at MIT Technology Review, where she earned a Newsbrief Award from the D.C. Science Writers Association.

She earned her bachelor’s degree in journalism at Ohio University and a master’s in science writing from Johns Hopkins University.

Chris Roush

Chris Roush was the dean of the School of Communications at Quinnipiac University in Hamden, Connecticut. He was previously Walter E. Hussman Sr. Distinguished Professor in business journalism at UNC-Chapel Hill. He is a former business journalist for Bloomberg News, Businessweek, The Atlanta Journal-Constitution, The Tampa Tribune and the Sarasota Herald-Tribune. He is the author of the leading business reporting textbook "Show me the Money: Writing Business and Economics Stories for Mass Communication" and "Thinking Things Over," a biography of former Wall Street Journal editor Vermont Royster.